EUVIMEDEUVIMED entdecken
Open Access

Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In Vivo

Prin Sungwan, Sonexai Kidoikhammouan, Unchalee Thonsri, Charupong Saengboonmee, Sopit Wongkham, Seiji Okada, Wunchana Seubwai

In Vivo · 2024

DOI: 10.21873/invivo.13693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Prin Sungwan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Science Program, Graduate School, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Indolizines, Cholangiocarcinoma, Cyclic N-Oxides, Pyridinium Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolizinesCholangiocarcinomaCyclic N-OxidesPyridinium CompoundsBridged Bicyclo Compounds, HeterocyclicXenograft Model Antitumor AssaysCell ProliferationAnimalsHumansMiceCell Line, TumorCyclin-Dependent KinasesBile Duct NeoplasmsApoptosisProtein Kinase InhibitorsAntineoplastic AgentsDrug Resistance, NeoplasmGemcitabineDeoxycytidineCell CycleDisease Models, Animal

Stichwörter der Autor:innen

Chemosensitizationcholangiocarcinomadinaciclibdrug resistancegemcitabine

Substanzen

dinaciclibIndolizinesCyclic N-OxidesPyridinium CompoundsBridged Bicyclo Compounds, HeterocyclicCyclin-Dependent KinasesProtein Kinase InhibitorsAntineoplastic AgentsGemcitabineDeoxycytidine

Autor:innen und Institutionen

  • Biomedical Science Program, Graduate School, Khon Kaen University, Khon Kaen, Thailand.
  • Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Department of Biochemistry, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
  • Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand.

Zitieren

APA

Sungwan, P., Kidoikhammouan, S., Thonsri, U., Saengboonmee, C., Wongkham, S., Okada, S., & Seubwai, W. (2024). Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In Vivo. In Vivo. https://doi.org/10.21873/invivo.13693

Vancouver

Sungwan P, Kidoikhammouan S, Thonsri U, Saengboonmee C, Wongkham S, Okada S, et al. Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In Vivo. In Vivo. 2024. doi:10.21873/invivo.13693

BibTeX
@article{Sungwan2024,
  author = {Sungwan, Prin and Kidoikhammouan, Sonexai and Thonsri, Unchalee and Saengboonmee, Charupong and Wongkham, Sopit and Okada, Seiji and Seubwai, Wunchana},
  title = {Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In Vivo},
  journal = {In Vivo},
  year = {2024},
  doi = {10.21873/invivo.13693}
}
Kostenlos starten →